M6PR/IGF2R double-knockout supplies therapeutic sources for mucolipidosis II and Niemann-Pick C2. [PDF]
Fujita T +3 more
europepmc +1 more source
From autophagy-lysosomal deficits to neurodegeneration in Niemann-Pick type C1 disease: implications for age-related neurodegenerative disorders. [PDF]
Kawachi Y +4 more
europepmc +1 more source
A Rapamycin Pharmacogenomic Approach for the Childhood Dementia Niemann-Pick C. [PDF]
Szenfeld B +6 more
europepmc +1 more source
Potential Mechanisms of Platelet Dysfunction and Bleeding in Acid Sphingomyelinase Deficiency. [PDF]
Sysoev M +3 more
europepmc +1 more source
Synthesis of N-Acetyl-D- and -L-Leucine-<sup>13</sup>C<sub>6</sub> Tool Compounds in Neurodegenerative Disease. [PDF]
Crepin D +10 more
europepmc +1 more source
Arimoclomol in infants with Niemann-Pick disease type C: Results from the phase 2/3 open-label pediatric substudy. [PDF]
Mengel E +6 more
europepmc +1 more source
Contradictory Effects on Hepatocytes in ASMD. [PDF]
Sysoev M +3 more
europepmc +1 more source
Stress and anxiety among caregivers of adult patients with Niemann-Pick Type C disease
Izabela Dawidowska-Nowak +2 more
doaj +1 more source
An Australian standard of care for Niemann-Pick disease type C. [PDF]
Tchan M +23 more
europepmc +1 more source

